Physician profile
Anthony V Deceanne
NPI 1083613293
$21,745.63
in general payments reported to CMS, 2019-2025
25 companies · $1,713 in 2025
The $1,713 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,282 · 2021: $971 · 2022: $1,920 · 2023: $1,519 · 2024: $1,960 · 2025: $1,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,144 · Education: $48.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,144.07 |
| Education | $48.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15,296.13 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Osiris Therapeutics INC. | $2,420.89 | 2019 | |
| Kerecis Limited | $1,335.94 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Next Science LLC | $334.81 | 2022-2024 | Blastx, Xperience, Surgx |
| Bone Support INC. | $333.42 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Wright Medical Technology, INC. | $318.71 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $311.55 | 2019-2023 | Gore Viabahn Endoprosthesis With Heparin |
| Treace Medical Concepts, INC. | $282.06 | 2022-2025 | |
| Organogenesis INC. | $189.55 | 2019-2021 | |
| Stryker Corporation | $175.66 | 2022-2024 | Sidekick |
| Baxter Healthcare | $112.96 | 2020-2022 | |
| Tenex Health INC. | $104.66 | 2020 | |
| Nestle Healthcare Nutrition INC. | $81.80 | 2023 | |
| Melinta Therapeutics, LLC | $75.52 | 2019 | |
| Aroa Biosurgery Incorporated | $63.51 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $56.48 | 2021-2023 | Snap, V.A.C. Dermatac, Activ.A.C. |
| Integra Lifesciences Corporation | $56.31 | 2019 | |
| Pfizer INC. | $49.17 | 2019 | |
| Sandoz INC. | $47.27 | 2019 | |
| Mimedx Group, INC. | $20.49 | 2025 | |
| Paratek Pharmaceuticals, INC. | $18.42 | 2025 | Nuzyra |
| Solventum Corporation | $17.38 | 2024 | V.A.C. Dermatac, Snap |
| Stimlabs LLC | $16.54 | 2025 | Corplex P |
| Aimmune Therapeutics, INC. | $14.46 | 2024 | |
| Misonix INC | $11.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Deceanne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.